Flagship Ventures Fund V, L.P. 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 5:08 pm Sale |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
Flagship Ventures Fund V, L.P. | 2,730,263 2.200% |
-5,250,000 (-65.79%) |
Filing |